# Cytalux

NDC: 81052-138
Generic name: Pafolacianine injection
Labeler / Manufacturer: On Target Laboratories, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20211129

FDA application: NDA214907

## Active ingredients

- PAFOLACIANINE SODIUM: 3.2 mg/1.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81052-138"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81052-138
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d21952b9-7c4e-3a56-e053-2a95a90a0ab0